A new study suggests that antibiotic use in the United State is not needed to protect yourself from the deadly and widespread antibiotic resistance that is ravaging the global health system.
The new study, conducted by researchers at the University of Kentucky Medical Center and the Vanderbilt University School of Medicine, found that there was no evidence that travelers from the Middle East, Africa, Asia, or South America needed to be taking any specific type of antibiotic to survive in the U.S. and be treated safely.
The study also found that the risk of contracting MRSA infections from those who traveled abroad was lower than that of Americans who stayed home.
“The findings are exciting,” said Dr. Joseph H. Lamm, the lead author of the study, in a news release.
However, as with any medical intervention, there is no safe level of antibiotic use. “
In general, antibiotic use is not necessary for the protection of the US population from the disease.
For example, a 2014 study from the Centers for Disease Control and Prevention found that only 15 percent of people who tested positive for MRSA were antibiotic-treated in the hospital and that many other factors could influence the outcome of the testing. “
Our study shows that there is still significant uncertainty surrounding the use of antibiotics when travelling overseas and the risks associated with the use.”
For example, a 2014 study from the Centers for Disease Control and Prevention found that only 15 percent of people who tested positive for MRSA were antibiotic-treated in the hospital and that many other factors could influence the outcome of the testing.
Another recent study found that antibiotic-resistant bacteria were found in a large percentage of the samples taken from the hands of some patients with UTIs and that the MRSA was more prevalent in those with UTI infections.
There is no evidence to suggest that antibiotics should be used to treat UTIs in the US.
Instead, there are studies to determine if there are other ways to treat these infections.
The CDC has also released guidelines that call for the use only of antibiotics prescribed by a doctor for a specific diagnosis.
However this is only a recommendation, and most physicians do not follow it.
Dr. Steven P. Lappert, who studies antibiotic resistance at Vanderbilt University, said that the new study shows the need for more information about the potential for resistant bacteria.
“We need to understand what is the impact of the different antibiotics on the human population,” he said.
“But more importantly, the risks and benefits of different types of antibiotic treatment are not well understood.”
The study, published in the journal Clinical Infectious Diseases, looked at data from 1,062 people who were screened for MRSE, which is resistant to a number of antibiotics, and then tested again for the other bacteria.
The researchers used data from the U-M data and analyzed it to determine which drugs were the most effective at preventing infection.
They also compared the risk for MRSEA to people who had tested positive and to people whose infections did not have MRSA.
The analysis showed that the overall risk of MRSEA was lower for those who had taken the antibiotic or those who were not.
For instance, in the study population, the risk was 0.05 percent for people who did not take antibiotics or 0.3 percent for those that had taken them, and 0.6 percent for the people who used antibiotics.
However for those with MRSEA, the data did not show that the risks were lower than for the general population.
For example in the data from people who took antibiotics, there was an overall risk reduction of 1.3 percentage points compared to the general populations.
But the risk reduction was lower when the patients had taken antibiotics in the past, meaning the benefit for those taking antibiotics in those settings was lower.
“This research is important because we need to make sure we understand how MRSA can occur and how to prevent it,” said Lappet.
The research also showed that for people in the Middle Eastern region, who were most at risk, the benefit was greater than for people living in the Americas and Asia.
For the people in Africa, the benefits were even greater than in Asia.
“Africa has a very low level of resistance to most antibiotics and so for them, taking antibiotics is really the best option,” said Hani Sohail, associate professor of preventive medicine at Vanderbilt and a co-author of the research.
“However, in many cases, they do need to take the antibiotics, like for example for their UTIs.
So for this study, we really needed to look at the effects of different antibiotics in these populations.”
Dr. Ladd W. O’Brien, professor of medicine at Duke University, added, “I think the important thing to note is that there are no real guidelines to prescribe or prescribe antibiotics when you travel.
There are also no guidelines for how to take them when you go back to the U!
So this is just a really exciting area of study to learn about.”
The researchers also found a small increase in the risk that